KCNV2-associated retinopathy, an autosomal recessive cone-rod dystrophy, has been associated with gene variants in KCNV2, which codes for Kv8.2 and is currently under investigation as a potential target for gene therapy [76]. This evidence concerns the gene KCNV2 and retinal disorder.